No results found.

Here are some suggested resources.

White Papers

Balancing the Demand for Deep Data with Patient Privacy. As pharma companies have become more sophisticated in their use of real-world evidence (RWE), they have moved beyond standard datasets from vendors to access a deeper and wider variety of datasets, often working in partnership with local health systems.

White Papers

De-identifying Unstructured Data to Enable Health Analytics. According to one organization, 80 percent of medical record data will be unstructured within the next two years. 

White Papers

Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials transparency.

White Papers

In the specialty pharmaceutical industry, patient privacy is crucial. Privacy can be a challenge for companies looking to gather and consolidate patient information from various sources.

Not finding what you're looking for?

Filter by Data Type